> top > docs > PMC:7195088 > spans > 46225-46478 > annotations

PMC:7195088 / 46225-46478 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
1395 89-97 Species denotes patients Tax:9606
1400 167-176 Species denotes influenza Tax:11520
1401 212-221 Species denotes influenza Tax:11520
1403 191-201 Chemical denotes umifenovir MESH:C086979
1408 80-88 Disease denotes COVID-19 MESH:C000657245

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T83 118-121 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T84 132-135 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T258 80-88 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T259 167-176 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T260 212-221 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T269 177-185 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T270 222-230 http://purl.obolibrary.org/obo/UBERON_0000158 denotes membrane

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T560 6-22 Chemical denotes antiviral agents http://purl.obolibrary.org/obo/CHEBI_22587
T561 102-113 Chemical denotes favipiravir http://purl.obolibrary.org/obo/CHEBI_134722
T562 132-156 Chemical denotes RNA polymerase inhibitor http://purl.obolibrary.org/obo/CHEBI_37416
T563 147-156 Chemical denotes inhibitor http://purl.obolibrary.org/obo/CHEBI_35222
T564 191-201 Chemical denotes umifenovir http://purl.obolibrary.org/obo/CHEBI_134730
T565 238-247 Chemical denotes inhibitor http://purl.obolibrary.org/obo/CHEBI_35222

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T14 222-237 http://purl.obolibrary.org/obo/GO_0061025 denotes membrane fusion

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T365 0-253 Sentence denotes Other antiviral agents currently being investigated in RCT for the treatment of COVID-19 patients are favipiravir, an RNA-dependent RNA polymerase inhibitor with anti-influenza activity, and umifenovir, and anti-influenza membrane fusion inhibitor [29].

2_test

Id Subject Object Predicate Lexical cue
32360444-32147628-22369769 249-251 32147628 denotes 29